Fingerprint
Dive into the research topics of 'PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma
Fiona Brown-Burke, Inah Hwang, Shelby Sloan, Claire Hinterschied, Jo Beth Helmig-Mason, Mackenzie Long, Wing Keung Chan, Alexander Prouty, Ji Hyun Chung, Yang Zhang, Satishkumar Singh, Youssef Youssef, Neha Bhagwat, Zhengming Chen, Selina Chen-Kiang, Maurizio Di Liberto, Olivier Elemento, Lalit Sehgal, Lapo Alinari, Kris Vaddi
Research output: Contribution to journal › Article › peer-review
3
Scopus
citations